AGRX

Agile Therapeutics
AGRX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

AGRX was delisted on the 25th of March, 2024.

Back to rankings

36 hedge funds and large institutions have $182M invested in Agile Therapeutics in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

64% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 11

Holders
36
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$50K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$953K
2
+$96.1K
3
+$42K
4
PFM
Parsec Financial Management
North Carolina
+$14.5K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$11.7K

Top Sellers

1
-$358K
2
-$171K
3
-$129K
4
VF
Virtu Financial
New York
-$116K
5
Jane Street
Jane Street
New York
-$37K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$4K
27
$4K
28
$4K
29
$3K
30
$2K
31
$2K
32
$1K
33
$379
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
1
2